Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Seibule approved in Japan for postprandial hyperglycemia

Oct. 14, 2005

Preclinical data on peptide YY3-36

Oct. 14, 2005

Recent Lilly and Bayer patents report novel agents for obesity and lipoprotein disorders

Oct. 14, 2005

Novel agents for treating endocrine-related disorders disclosed in recent patents

Oct. 14, 2005

Phase III Evamist study completes enrollment

Oct. 14, 2005

Treatment completed in phase II/III trial of Diamyd

Oct. 14, 2005

Treatment completed in phase I/II study of GTP-200 for cancer cachexia

Oct. 14, 2005

European approval for NovoMix 50 and NovoMix 70 insulin analogues

Oct. 14, 2005

Snapshots on studies reported at the 2005 ASBMR and NAMS meetings

Oct. 13, 2005

Extension studies of asoprisnil to be amended

Oct. 13, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
Regeneron’s fianlimab lags in melanoma, does $2.3B deal with Parabilis
BioWorld
Regeneron Pharmaceuticals Inc. stuck with the tradition of releasing bad news on Friday afternoon and good news on Monday morning with a pair of announcements...